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After remaining  elusive for many years,  the  receptor on  MHC-restricted T 
cells responsible for antigen/MHC recognition has now been identified by means 
of antireceptor  mAb  (1-6).  Most  of these  antibodies  were  detected  by  their 
ability to inhibit the functioning of the particular monoclonal T  cell population 
against which they were raised. However, early studies by Infante et al. (7) with 
polyvalent antibodies capable of stimulating cloned alloreactive T  cells have now 
been confirmed in our own studies using both antisera and mAb (3,  8-10).  In 
our  own  studies,  monovalent  Fab  fragments  of  antireceptor  antibody  were 
inhibitory (8), while several other investigators (1 1-13) have shown that inhibi- 
tory  mAb  coupled  to  Sepharose  beads  will  stimulate  the  specific immunizing 
cloned T  cell line. 
The reason for the differences in" the behavior of these cloned T  cell lines is 
not  known.  In  the  present  experiments,  we  have  examined  several  possible 
mechanisms that might account for the behavior of our system, and can safely 
conclude that it represents an unusual property of the cloned T  cell line used to 
raise the antireceptor antibody. The striking tendency of this cloned T  cell line, 
D 10.G4.1, to become activated upon encountering antireceptor antibodies may 
also account for its remarkable ability to induce antibodies  that stimulate  it to 
secrete lymphokines and, in the presence of IL-1,  to proliferate. We can show 
that the B cell response to the receptor of D 10.G4.1  is independent of other T 
cells  both  in  vivo and  in  vitro.  This  has  allowed  us  to  prepare  a  battery  of 
antireceptor mAb against  D10.G4.1  that will be useful in further analyzing the 
interaction of antibody, antigen,  and  MHC-encoded molecules with the T  cell 
receptor. 
Materials and Methods 
Animals.  BALB/cByJ mice were purchased from The Jackson Laboratory, Bar Har- 
bor, ME; BALB.B and BALB.K mice were bred at Yale by Dr. Donal B. Murphy; nude 
mice were purchased from Life Sciences, North St. Petersberg, FL; Sprague-Dawley rats 
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were purchased from Carom Research Lab Animals, Wayne, NJ. 
Antibodies.  The anti-D10 receptor mAb 3D3 has been extensively characterized (3, 
8-10); its Fab fragment was prepared as described (8). mAb KJ-16 was a kind gift of Drs. 
Kappler and Marrack, and was used as a culture supernatant without further purification 
(6). Monoclonal anti-brain-associated T cell antigen (anti-BAT) ~  was prepared as an ascites 
in nude mice as previously described (14).  Anti-D8 antibody was prepared as described 
previously (3). 
Cloned T Cell Lines.  Cloned T  cell lines were prepared and maintained as previously 
described (3,  15).  Cloned line D10.G4.1  (D10) is specific for hen egg conalbumin (CA) 
plus I-A  k and is alloreactive to I-A  b (3, 8). Cloned T  cell line D8 from the same mouse is 
specific for hen OVA and I-A  k (3). A panel of BALB/cByJ, BALB.B, and BALB.K cloned 
T  cell lines specific for OVA and self Ia was previously described (16). 
T  Cell Proliferation  Assays.  Typically, 2  ×  104 cloned T  cells were added  to 200-#1 
cultures  in  flat-bottom microtiter trays in  Click's EHAA  medium with  10%  FCS.  Cell 
growth  was stimulated  by mAb or  by antigen  plus  3  ×  105  syngeneic,  mitomycin C- 
inactivated spleen cells,  as previously described (3,  15). In some experiments, antibodies 
were added  to T  cells before the  addition  of antigen  and  feeder cells.  After 48  h  of 
culture,  1 ~Ci  [3H]TdR  was  added  to  each  well,  and  the  cells  harvested  16  h  later. 
Incorporated TdR was determined in triplicate cultures. 
Interleukins  and Interleukin  assays.  IL-1  was prepared by stimulating  P388.D1  cells 
with  1 ~g/ml LPS for 25 h  (3). Activity was determined by costimulation of the growth 
of D10 cells (9).  IL-2 was either the crude supernatant of rat spleen cells stimulated for 
24 h with Con A or recombinant-derived human IL-2 donated by Dr. Richard Robb, E. 
I. du  Pont de  Nemours, Glenolden,  PA.  IL-2 was assayed by culturing with  104 HT-2 
indicator cells for 36 h, followed by a  16-h pulse with [3H]TdR. 
Immunization  and  Production  of mAb.  Nude  or  BALB.K  mice  or  Lewis  rats  were 
immunized intraperitoneally with  107 viable D 10 cells.  At various times later, they were 
boosted intravenously with live D 10 cells, and 3 d later their spleen cells were fused with 
the  nonsecreting  myeloma P3X63/Ag-8.653  as  previously described  (3,  17).  Cultures 
were fed after the first week with RPMI 1640 plus 5% FCS, and supernatants were tested 
for their ability to stimulate DI0 cells plus IL-1 or to inhibit their response to CA plus 
I-A  k.  Positive  wells  were  expanded,  cloned  by  limiting  dilution,  and  rescreened  for 
stimulation of D10 plus IL-1. 
In Vitro Production  of Anti-DlO Antibody.  B cells from mice primed in vivo with  107 
D 10 cells 2-4 wk previously were prepared by treating spleen cells with anti-BAT antibody 
followed by rabbit complement, as previously described (18).  These cells were cultured 
alone or with  10 4 mitomycin C-treated  D10 or D8 cells for 6  d.  Culture supernatants 
were tested at a dilution of 1:6  for their ability to stimulate D10 cells in IL-1; positive 
wells were rescreened for blocking by 3D3 Fab fragment. 
Results 
DIO Cells Are Activated by KJ-16,  an Anti-T Cell Receptor mAb that Inhibits the 
Responses of Other Cloned T  Cell Lines.  The cloned T  cell line D10 responds to 
soluble  3D3  antireceptor  mAb  at  1  ng/ml;  aggregation  of  this  antibody  on 
Sepharose beads does not alter its behavior (J. Kaye, unpublished observations). 
However, it was possible that aggregates in the preparation of 3D3 were respon- 
sible for the ability of this antibody to stimulate D10. To examine this question, 
we obtained an mAb, KJ-16, specific for shared portions of the T  cell receptor, 
from Drs. Kappler and Marrack. This antibody reacts with T  cells of clone D 10, 
but not T  cells of clone D8, as determined by FACS analysis (not shown). Soluble 
KJ-16 stimulates  D10  cells to secrete  IL-2 (not shown) and,  in  the  presence of 
IL-1, to proliferate, as shown in Table I. Although not as active in this regard as 
l Abbreviations used in this paper:  BAT, brain-associated T  cell antigen; CA, hen egg conalbumin. TITE  ET  AL.  191 
TABLE  I 
mAb KJ-16 Stimulates Cloned T Cell Line D IO But Not D8 to Proliferate 
Cloned T  cell  IL-I* 
line* 
T  cell proliferative response to: 
0  3D30  KJ-16 1:101  KJ-16 1:100  Anti-D8  q 
D  10  -  218  12,665  4,662  5,965  -- 
+  250  173,340  39,153  38,450  -- 
D  8  -  104  --  132  130  3,610 
+  82  --  146  114  52,293 
* 2  x  104 cloned T  cells per well in 200-gl cultures. Triplicate cultures pulsed after 48 h  with  1 ~tCi 
[3H]TdR and harvested 16 h  later.  Mean cpm is reported. 
* 4% of supernatant from LPS-stimulated P388.D1  cells. 
mAb 3D3 final concentration 5 ng/ml. 
It KJ- 16 culture supernatants added at  1:10 or 1 : 100 final dilution. 
1 Anti-D8 serum prepared as previously described (3) and added at  1:150 final dilution. 
soluble 3D3 antibody, this behavior of KJ-16 is in marked contrast to its ability 
to inhibit the proliferation of several other cloned T  cell lines to stimulation by 
antigen plus self Ia, as reported previously (6,  16) and shown in Table II. Thus, 
we have examined the responses of several cloned T  cell lines to KJ-16 and find 
that, of cloned lines reactive with this antibody, only D 10 responds to the soluble 
antibody by IL-2 secretion and proliferation. 
DIO Cells Require Neither APC nor Cell-Cell Interaction in Responding to Antire- 
ceptor Antibody.  While soluble antireceptor antibody clearly activates D10 cells, 
it is possible that residual APC present in the culture are involved in this response. 
Alternatively, D10 cells may present antireceptor antibodies to one another, one 
cell serving to aggregate the antibody for another. To examine these questions, 
D 10 cells were purified from culture by FicolI-Hypaque centrifugation 3 wk after 
last receiving feeder cells, and then added to cultures containing 3D3 and IL-1. 
Both I L-2 secretion and D 10 proliferation were determined and plotted against 
the cell number per well (Fig.  1).  On this log-log plot, the response is linearly 
related to the cell number, and the titration curve has a slope of approximately 
one. Thus, only a single cell type, D 10, appears to be limiting. In addition, when 
feeder cells are used as a source of IL-1 (Table III), their FcR for IgG1/IgG2b 
recognized by mAb 2.4G2 were required for the response to rabbit anti-mouse 
brain sera, but not for responses to the IgG1 antibody 3D3. Thus, FcR on T  or 
B cells do not play a detectable role in this response. To confirm the finding that 
cell interactions are not required for D 10 responses to 3D3, we plated D 10 cells 
at 0.3  cells/well in flat-bottom microtiter plates, identified cultures containing 
single cells in an inverted microscope, and added 3D3  plus  IL-1, or  medium 
alone to such wells. Wells were inspected daily, and the number of cells per well 
was recorded.  Soluble  3D3,  at  10  ng/ml, plus  IL-1  (5%)  stimulated the great 
majority of D 10 cells to divide for at least 3 d without further additions (Fig. 2), 
with a division rate of>l per 24 h. This strongly suggests that 3D3 can stimulate 
D 10 cells directly in the absence of APC, and that the great majority of cells in 
bulk cultures of D 10 cells can respond in this way. 
D I O Cells Give Rise to a High Frequency of Stimulating mAb.  In our initial study 
of D 10 cells, we observed a very high titer of stimulating, clone-specific antibodies 
in  the sera of BALB.K mice immunized with  D10  cells (3).  We were able  to 192  RECEPTOR-SPECIFIC  T-DEPENDENT  B  CELL  ACTIVATION 
TARLE  II 
mAb KJ-16 Inhibits Response of Cloned T Cell Lines to Antigen 
Presented by Syngeneic Feeder Cells 
Cloned T cell  Stimulator cells*  "~  'l~Ant:~en0 
line* 
T cell proliferative 
response in presence of: ! 
0  KJ-161 
8B5  C57BL/6  -  2,343  2,491 
+  42,748  16,911 
8B6  C57BL/6  -  701  661 
+  45,727  26,433 
8B6  C57BL/6  -  10,869  1,820 
+  144,480  37,502 
8D3  BALB/c  -  6,957  4,945 
+  144,480  55,987 
8D 11  BALB/c  -  2,967  3,164 
+  51,293  19,275 
AK-5  BALB.K  -  928  458 
+  22,427  3,007 
AK-8  BALB.K  -  363  311 
+  31,074  1,198 
AK-I**  BALB.K  -  6,856  8,106 
+  42,370  33,055 
JBr-2**  BALB.K  -  470  553 
+  15,742  23,446 
* Clones 8B5 and 8B6 are BALB.B ceils specific for OVA/I-A  b, while 
8D3 and 8D11 are BALB/c cells specific for OVA/I-A  d (16); clones 
AK-1, AK-5, and AK-8 are AKR/J clones, and cloneJBr-2 is a B10.BR 
clone, all specific for CA/I-A  k (our unpublished results).  2 ×  104 T 
cells added per well, Each cloned line was tested at least twice; repre- 
sentative data are shown. 
* 5 ×  105 mitomycin C-treated spleen cells were added per well. 
0 OVA or CA was added to 100 #g/well. 
I 200-#1 cultures were established in the presence or absence of KJ-16, 
which was added to cloned T cells for 60 min at 37°C before adding 
stimulator cells and antigen. Triplicate cultures pulsed after 48 h with 
1 #Ci [SH]TdR and harvested  16 h later.  Mean cpm are shown; SD 
(< 20% of mean) are omitted. 
1 Medium or KJ-16 culture supernatant was added to a final concentra- 
tion of 1:4. 
** Clones AK-1 andJBr-2 are KJ-16 negative. 
isolate a  stimulating mAb from just 60 parent wells showing hybridoma growth; 
a  second  positive  well  was  lost  before  cloning.  We  have  now  repeated  this 
experiment with  two  more  BALB.K mice, and have  found  19  positive parent 
wells from  a  total  of 560  showing growth.  We  have  been able to  clone  17  of 
these  parent wells, and all  yielded mAb  that  stimulate clone D10.  Five of the 
nine cloned cell lines tested are completely inhibited by 3D3  Fab and are thus 
directed at an epitope on the receptor close to or identical to that recognized by 
3D3, as shown in Table IV, and the response to the other four is partially but 
significantly inhibited by 3D3  Fab. These results stand in stark contrast to  the 
difficulties we and other laboratories have had in raising mAb to most cloned T 
cell  lines (2,  4,  5).  For  instance,  Kappler  et  al.  (12)  report  screening  15,000 
parent wells to obtain two antireceptor mAb. We find only stimulating mAb; we TITE  ET  AL.  193 
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FIGURE  1.  Dose-response analysis of the activation of DI0 cells by 3D3 and IL-1. 0.2-ml 
cultures containing various numbers of DI0 cells,  1:1,000 human IL-I, and 50 ng/ml 3D3 
were established, and [SH]TdR incorporation after 3 d  (m) was determined by pulsing the 
culture for the final 16 h.  In addition, culture supernatants at 50% (O) and 10%  (@) were 
analyzed for their ability to induce proliferation in HT-2 cells (104 cells/well) in 24-h cultures 
pulsed for the final 4 h with 1 ttCi [SH]TdR. Slopes (m) were determined by linear regression 
analysis for best fit. 
TABLE  III 
3D3 Does Not Require Interaction with FcR to Induce D IO Proliferation 
T cells*  Accessory cells*  Stimulus  ~  Anti-FcR  I 
Response  I 
Exp. 1  Exp. 2 
D10  BALB.K  --  -  63  3,135 
D 10  BALB.K  3 D3  -  14,970  56,155 
D 10  BALB.K  3D3  +  13,353  45,985 
D I 0  BALB.K  RAMBr  -  13,306  59,686 
D 10  BALB. K  RAMBr  +  63  15,619 
DI0  --  3D3  -  504  1,811 
* 2 ×  104 cloned T  cells per 0.2-ml culture. 
* 2 x  105 mitomycin C-treated spleen cells per 200-#1 culture. 
§ 1:1,000 3D3 culture supernatant or rabbit anti-mouse brain serum (RAMBr) at 1:100. 
" 1 ttg/ml mAb 2.4G2. 
Mean cpm [3H]TdR incorporation of triplicate cultures pulsed for the final 16 h of a 65 h culture 
period. 
have never  observed  an mAb  to  D 10 cells that inhibited their activation by CA 
plus  I-A  k,  although  we  have  screened  nearly  1,000  parent  wells  for  such  an 
activity. 
Evidence that DIO Receptors Interact Directly with Complementary Molecules on B 
Cells in Inducing the Anti-DlO Antibody Response.  The  unique  characteristics  of 
the  D10  clone  described  above,  namely  its  ability to  be  stimulated  by  soluble 
antireceptor  mAb  and  its striking ability to generate  antisera and  mAb  that will 
activate it via its receptor  for CA plus I-A  k (3), taken together  with the ability of 194  RECEPTOR-SPECIFIC  T-DEPENDENT  B  CELL  ACTIVATION 
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FIGURE  2.  Direct determination of the ability of single D10 cells to respond to 3D3 and IL- 
l. Flat-bottom microtiter plates were seeded with 0.3 D10 cells per 0.2-ml culture; some were 
also given  10 ng/ml 3D3 and 5%  murine IL-1  (A).  Individual wells were inspected and seen 
to contain one D10 cell at time 0.  Cultures were stimulated with  3D3  plus IL-1  (A), or left 
unstimulated (B).  Mean number of cells per well in A (Q) or B (O) is plotted in C. 
3D3-stimulated D10 cells to activate purified resting B cells to proliferate and to 
secrete Ig (18), suggested that D10 cells might stimulate B cells bearing comple- 
mentary  Ig  receptors  by a  direct  receptor-receptor  interaction.  To  test  this 
hypothesis, B cell responses to D10 cells were examined in the absence of other 
T  cells. This was done in two ways. First, nude mice were immunized with D10 
cells in the same way as BALB.K mice, and their spleen cells were harvested and 
fused with myeloma cells. Of 297 wells with growth,  15 primary wells were found 
to stimulate DI 0 cells. After a growth crisis, four of these yielded subclones that 
stimulated  D10  ceils.  We  have  not  yet  determined  whether  these  mAb  are 
specific for D 10 receptors, although this seems likely. Thus, nude mice will make 
a  stimulating  antibody response to the receptor on DI0 cells under conditions 
analogous to those in  euthymic mice, and  the yield of positive wells is ~1/20, 
although in this case the recioning efficiency was lower for unknown reasons. 
To more directly assess the ability of D10 cells to directly activate B ceils,  10 4 
mitomycin C-treated D 10 cells were cultured with 4 x  105 purified B cells from 
D10-primed BALB.K mice. Supernatants  of such cultures were tested for their 
ability to stimulate D10 cells to proliferate in the presence of IL-1. Whereas 2% 
(1/48) of B cell cultures without D10 cells gave significant levels of stimulation, 
17 of 192 wells (8.3%) with D10 cells gave significant levels of proliferation.  Of 
these, 15 of 17 stimulated strongly on repeat testing, and were inhibited by 3D3- 
Fab, while the one positive control supernatant  was negative on repeat testing 
(Table V). 
A  second experiment  compared  D10 cells with D8 cells, and found that  the 
3D3-inhibitable  anti-D10  antibody response occurred  using  D10 cells, but not 
D8 cells.  Thus,  purified  B cells can  be stimulated  by clone  D10 cells to  make TITE  ET  AL.  195 
TABLE  IV 
Anti-DlO mAb that Stimulate DIO Growth Are Directed at the Same 
or Closely Associated Sites as 3D3 
mAb* 
D 10 proliferative response in the 
presence of:* 
0  3D3-Fab  a 
Exp.  1 
0  2,800  2,800 
3D3  136,000  4,100 
193.6  112,700  6,100 
193.8  42,600  2,600 
193.9  94,900  2,700 
193.5  35,000  17,000 
193.10  107,500  47,000 
193.13  77,700  13,000 
Exp. 2 
0  5,000  16,000 
3D3  380,000  22,000 
193.12  177,000  17,000 
193.14  17,000  11,000 
193.16  115,000  119,000 
Exp. 3 
0  10,700  22,800 
3D3  324,000  23,500 
193.16  189,000  60,700 
* 25 #1 3D3 at 100 ng]ml or unknown supernatant of BALB.K anti-Dl0 
mAb. 
* 104 D10 T  cells in 200 #1 Click's EHAA plus 10% FCS and 5% P388.D1 
supernatant as a source of IL-1. After 48 h,  1 ttCi [SH]TdR was added 
per culture, and means of triplicate SH incorporation determined 16 h 
later. 
0 The Fab fragment of 3D3,  5 #g/ml (Exps.  1 and 2) or 25 ttg]ml (Exp. 
3), was added to culture. In control experiments, the D10 response to 
KJ-16, Con A, PHA, or recombinant IL-2 is not inhibited by >25% by 
3D3-Fab. 
antireceptor antibody in  vitro  in  the  absence  of contaminating T  cells.  The 
precursor frequency of such B cells appears to be low. This is not a polyclonal 
antibody response, as polyclonal responses require either antigen or antireceptor 
antibody (18). 
Finally,  rats  immunized  with  D10  cells  will  also  produce  antibodies  that 
stimulate clone D10  cells  specifically (Table VI).  While T  cells are present in 
these rats, it seems likely that this again reflects direct receptor-receptor inter- 
action of T  and B cells across a species difference. 
Discussion 
The cloned T  cell line D 10 can be stimulated by soluble antireceptor mAb to 
secrete IL-2 and, in the presence of IL-1, to increase its level of receptors for 
IL-2 and proliferate in response to its own IL-2 (3, 8-10). This stands in contrast 
to our own experience with cloned T  cell lines, and to that of other investigators. 196  RECEPTOR-SPECIFIC  T-DEPENDENT  B  CELL  ACTIVATION 
TABLE  V 
Stimulation of DlO Cells by Supernatants of BALB.K B Cells 
Cultured with D IO Cells: Inhibition  by 3D3-Fab 
Supernatant* 
Proliferative response of 
D10 cells plus IL-1 * 
Without 3D3-Fab  With 3D3-Fab  § 
0  476  300 
3D3 m  111,370  270 
1A10  29,142  451 
1A12  9,433  3,884 
1B7  15,058  2,139 
1C6  14,196  1,665 
IG12  37,260  928 
2Cll  18,785  310 
2D8  46,212  614 
2Ell  35,153  465 
* Supernatants of cultures of 4  ×  105  BALB.K splenic B ceils cultured 
with  104  mitomycin C-treated D10  cells for 6  d; only representative 
wells shown. 
* 25 ~1 of supernatant was added to 125/A with 104 D10 cells and 6% IL- 
l  for 48 h.  1/~Ci [SH]TdR was added for the final 16 h of culture, and 
responses were determined. 
0 5 ~g/ml Fab fragments were added to cultures. In control experiments, 
3D3-Fab  inhibited  3D3-driven  D10  responses by  95-100%,  Con  A 
responses by 0-8%, PHA responses by 0-16%, and recombinant IL-2 
responses by 0-26%. 
! 3D3 added at 100 ng/ml. 
TABLE  VI 
Rat Anti-DlO Sera Induce DIO But Not D8 Proliferation  in the Presence of lL-1 
T  Clone*  IL- 1  *  Antiserum  0 
Response  I 
Exp. 1  Exp. 2  Exp. 3  ~ 
D10 
D8 
-  --  154  54  33 
+  --  68  37  158 
+  RaD10.1  1:100  20,260  4,182  1,001 
+  RaD10.1  1:300  3,675  ND  ND 
+  RaD10.2  1:100  32,167  13,972  24,943 
+  RaD10.2  1:300  16,325  ND  ND 
-  --  75  17  64 
+  --  177  34  128 
+  RaD10.1  1:100  46  35  96 
+  RaD10.2  1:100  83  35  79 
+  Anti-D8 1:200  ND  21,656  ND 
* 2 ×  104 cloned T  cells per 0.2 ml culture. 
* 1% of an IL-l-rich PB88.D1  supernatant. 
Rat anti-D10.G4.1  (RaD10);  1 and 2 denote sera from individual animals; preimmune normal rat 
serum does not stimulate D10 cells (data not shown). 
Mean cpm [3H]TdR incorporation of triplicate cultures pulsed for the final 16 h of a 65 h culture 
period. 
Exps. 1 and 2 are duplicate experiments using the identical sera; Exp. 3 uses a later bleed from the 
same animals. TITE  ET  AL.  197 
The present studies show that D 10 cells differ from other cloned lines prepared 
by  the  same  technique  in  our  laboratory,  since  mAb  KJ-16,  specific  for  a 
determinant found on receptors of-25%  of T  cells in most strains, stimulated 
D10  cells in soluble form but inhibited several other cloned T  cell  lines with 
which it reacted (all six tested herein). However, the ability of soluble antibody 
to activate rather than inhibit cloned T  cell lines is not confined to D10; Infante 
et al. (7) reported antisera that stimulate cloned alioreactive T  cells, and we have 
observed  similar behavior with  a  second cloned T  cell  line,  D8,  as  reported 
earlier (3) and confirmed here (Tables I and VI). We observe no difference in 
the response  of D10  cells to soluble or Sepharose bead-conjugated 3D3  (not 
shown). Both preparations stimulate to the same titer, and both require IL-1 to 
observe D 10 growth. 
A  second,  and  perhaps  related,  unusual characteristic of D10  cells  is  their 
ability to induce stimulating antireceptor antibodies in vivo. As judged by our 
own experience over several years with numerous cloned T  cell lines, and the 
difficulty  other investigators have experienced in attempting to raise antireceptor 
antibodies to cloned T  cell lines, this is a remarkable property of D10 cells. This 
is  confirmed in  the  present  experiments  by  the  finding of a  frequency of  1 
hybridoma in 30 that stimulates clone D10 cells in four separate fusion experi- 
ments. That a  similar frequency is observed using nude mice suggests that T 
cells other than D10  itself are not required for this response.  This is strongly 
supported by the findings presented in Table V, in which B cells are stimulated 
in vitro by D10 cells to secrete anti-D10 antibody. 
The basis for the unusual ability of D10 cells to be stimulated by antireceptor 
antibody is clearly the property of single cells,  and does not reflect either the 
antibody or occult cell interactions. The cellular basis for this unusual character- 
istic  is not known. We are presently preparing variants of D10 that respond to 
Sepharose-bound 3D3 but not to soluble 3D3. Comparison of the variant to the 
parent line may give insight into this question. 
The ability of D 10 cells to activate B cells to secrete stimulating antireceptor 
antibodies, many (and perhaps all) of which are clearly directed at the antigen- 
recognizing site  on  the  receptor,  since  they are  inhibited by  3D3-Fab  (8),  is 
believed to reflect a  direct interaction between the receptor on D 10 cells  and 
the complementary B cell Ig. We propose that this interaction leads to aggrega- 
tion of the D10  receptor, which in turn activates D10 cells to function as Th 
cells.  This argument is strongly supported by our previous finding that soluble 
3D3 can activate D10 cells to induce B cell proliferation and Ig secretion (18), 
and that this is as potent a stimulus of B cell responses as is antigen plus self Ia 
on the B cell surface. 3D3-Mediated stimulation of B cells is not dependent on 
FcR on B cells, as shown previously also for anti-D10 antisera (3  and J.  Kaye, 
unpublished results). Thus, we believe that the production of antibody stimula- 
tory for D 10 cells serves as a measure of direct stimulatory interactions of T  cell 
and B cell receptors. 
However,  this  receptor-receptor  interaction  should,  in  theory, apply  to  all 
cloned T  cell lines. Why is D10 unusual in its ability to stimulate the B cells so 
contacted to secrete antibody and fuse to become hybridomas? The answer may 
lie in three unusual characteristics of D10  cells.  The first is their ability to be 198  RECEPTOR-SPECIFIC  T-DEPENDENT  B  CELL  ACTIVATION 
stimulated by soluble as well as Sepharose-bound antireceptor antibody. If a Tb 
cell is inhibited by soluble antibody, then even if it is activated to help a  B cell 
whose Ig is complementary to the T  cell receptor and hence activates the T  cell, 
the  Th  cell  will  be  inhibited  by the  antibody  once  the  B  cell  commences  Ig 
secretion, and will thus stop providing helper signals. D10 cells, by contrast, will 
continue  to be stimulated  in  this  situation,  and  will  continue  to secrete helper 
lymphokines.  Second,  D10  secretes  potent  helper  lymphokines  upon  receptor 
crosslinking by antibody, as determined by its ability to activate resting and xid 
B cells in the absence of direct cell-cell contact (18). Furthermore,  D 10 produces 
much more IL-2 than any other cloned T  cell line we have observed. Thus, D10 
is simply a more efficient Th cell than most other cloned T  cell lines. In analyzing 
responses to phosphorylcholine, Kim et al. (19) confirmed this conclusion. Third, 
and perhaps most important,  D 10 cells have no cytotoxic capacity, whereas most 
of our cloned T  cell  lines  can  kill  or inhibit  the  growth  of B  lymphoma  lines 
bearing appropriate  antigen  plus  Ia  complexes (20-22).  Recently,  Lancki and 
Fitch (23) have shown  that a  cytolytic T  cell line can  kill  a  hybridoma making 
antireceptor antibody, while Kranz  et al.  (24) have shown that  cells chemically 
coupled with antibody directed at the receptor of a cytolytic T  cell are also killed 
by  such  cells.  Thus,  it  may  be  especially  difficult  to  raise  mAb  directed  at 
receptors  on  such  cells,  and  dead  or  inactivated  T  cells  might  be  the  best 
immunogen  in  these  cases.  In  the  case of Th  cells,  we find  that  most  of the 
cloned lines we have produced make cytotoxic molecules, such as lymphotoxin 
(22, 25) or lytic lymphokine (26). While such cells can serve as Th cells, they do 
so far less well than  does D10 (19).  Such cytolytic, Ia-restricted  T  cells clearly 
kill  activated B cells, and can  be shown to suppress both specific (27,  28) and 
polyclonal (J.  Tite,  unpublished  results)  B  cell responses.  The  combination  of 
activation  by soluble antireceptor antibody, high  helper efficiency, and  lack of 
cytolytic capacity may well account for the striking ability of D 10 cells to induce 
antireceptor antibodies in mice and rats by direct interaction with B cells bearing 
complementary receptors. 
This experimental system may provide an interesting model for studying the 
interaction  of T  and  B lymphocyte receptors in the generation and expression 
of the T  and B cell repertoires. The assay system is highly sensitive and specific, 
and  the expansion of our panel  of antireceptor  mAb could yield antibodies to 
recurrent  T  cell idiotypes; recurrent  Ig idiotypes have played a  central  role in 
examining the B cell receptor repertoire. Clearly, in the D 10 system, both the B 
cell and the T  cell are activated to proliferate and secrete. As argued above, this 
response is probably an exaggeration of the normal response occurring when T 
cells and B cells with complementary receptors interact.  While Eichmann  et al. 
(29),  using  idiotype-immunized  T  cells,  have  shown  that  such  cells  can  drive 
antigen-independent  activation of idiotype-bearing B cells to secrete antibody, a 
finding confirmed subsequently by Pierce et al. (30) and by Cerny and Caulfield 
(31), many investigators have not observed direct B cell activation by antiidiotypic 
T  cells (32-39). Rather, such studies have revealed an influence on the activation 
of B cells by antiidiotypic T  cells; full B cell activation requiring a conventional, 
antigen  plus  Ia-specific  Th  cell  as  well.  It  is  interesting  to  speculate  that 
antiidiotypic Th cells might resemble D10 in their interaction with B cells. Such TITE  ET  AL.  199 
cells have been shown in several systems to depend upon B cells or their products 
for their differentiation (32, 39).  Thus, Ig appears to play a role in shaping the 
antiidiotypic T  cell repertoire. Antiidiotypic T  cells,  in turn, may further shape 
both the B and the T  cell repertoire through further receptor-receptor interac- 
tions  (40,  41).  Having a  simple  and  highly sensitive experimental  system  to 
explore these questions should make it easier to monitor these effects. 
Summary 
A murine cloned Th cell line specific for the antigen conalbumin in the context 
of self I-A molecules can be activated by low concentrations of soluble antirecep- 
tor mAb. By using an antireceptor mAb to shared antigenic determinants on T 
cell receptors, we have shown that the ability to be activated by soluble antire- 
ceptor mAb is an  unusual, although not unique, feature of this cloned T  cell 
line. This activation does not involve occult APC, FcR, or interaction between 
individual cloned T  cells, as limiting-dilution analysis shows that individual cells 
of this clone will grow in the presence of the antireceptor antibody and IL-1 as 
stimulus. This cloned T  cell line is highly immunogenic in vivo, giving rise to 
antireceptor antibodies that stimulate its growth in  both mice and rats.  This 
response is not dependent upon exogenous T  cells.  Rather, the clone directly 
interacts with complementary B cells, as shown by the production of mAb in 
nude mice, and by production of stimulating antireceptor antibodies by purified 
B cells cultured with cloned Th cells in vitro. Several features of this cloned Th 
cell  line,  most especially its  ability to  be  activated, rather  than  inhibited, by 
antireceptor antibodies, may account for its striking ability to directly activate B 
cells bearing complementary receptors. The direct interaction of the cloned Th 
cell with B  cells bearing complementary receptors  may serve  as  a  model  for 
receptor-receptor interactions in the generation of both T  and B cell repertoires. 
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